Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Botanic Healthcare Pvt Ltd. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, MOREAU, NASHARA LOUISE. As the only examiner currently reviewing the company's applications, MOREAU, NASHARA LOUISE is also the busiest examiner, holding 1 busiest examiner pending office action. This concentration means the company's current prosecution is entirely dependent on this single individual.
The 1 pending office action is situated within 1 distinct art unit. This indicates that the subject matter of the filing is focused within a specific technical division at the USPTO. For a practitioner, having 1 distinct examiner and 1 distinct art unit for the entire pending portfolio means there is no internal data for comparison. The outcome of the 1 pending office action will be determined by the specific standards of the Biotechnology & Pharmaceuticals area and the individual approach of MOREAU, NASHARA LOUISE. This singular focus on 1 pending office action allows for a very targeted prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOREAU, NASHARA LOUISE | 1 | 80.0% | -100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18746383 | COMPOSITION OF A SWEET CORN SILK EXTRACT FOR MEDICINAL USE AND A METHOD THEREOF | MOREAU, NASHARA LOUISE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18746383 | COMPOSITION OF A SWEET CORN SILK EXTRACT FOR MEDICINAL USE AND A METHOD THEREOF | MOREAU, NASHARA LOUISE | 1655 | §101§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial